Fumihiko Ando

Dr. Fumihiko Ando

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2025 in Cancers
Verified
Journal Article
Open access
PDF file
FAFumihiko Ando
Fumihiko Ando
AMAkihisa Matsuda
Akihisa Matsuda
YMYuji Miyamoto
Yuji Miyamoto
Yu SunakawaYu Sunakawa
Yu Sunakawa
TATomoko Asatsuma-Okumura
Tomoko Asatsuma-Okumura
HYHiroshi Yoshida
Hiroshi Yoshida
Background: Immune checkpoint inhibitors (ICIs) have limited efficacy in proficient mismatch repair (pMMR) and microsatellite stability (MSS) metastatic colorectal cancer (mCRC). Inhibition of vascular endothelial growth factor (VEGF) or cytotoxic chemotherapy can boost immunogenicity and has the potential to upregulate ICI efficacy. Methods: A comprehensive electronic literature search was conducted up to April 2025 to identify randomized controlled trials comparing cytotoxic chemotherapy plus bevacizumab with or without ICI. The primary outcome was progression-free survival (PFS), and secondary outcomes were overall survival (OS), objective response rate (ORR), and severe adverse events (AEs: grade 3 or more). A meta-analysis was performed using random-effects models to calculate hazard ratios (HRs) or odds ratios (ORs) with 95% confidence intervals (CIs). Results: Four studies involving 986 patients (With-ICI group, n = 651; Without-ICI group, n = 335) were included. The meta-analysis demonstrated a significant improvement in PFS in the With-ICI group compared with the Without-ICI group, with an HR of 0.82 (95% CI: 0.70–0.96, p = 0.01) without statistical heterogeneity. No significant improvements were observed between the With- and Without-ICI groups in OS and ORR meta-analyses, but the With-ICI group had a favorable trend in OS. A significant increase in serious AEs was not observed in the With-ICI group. Conclusions: This meta-analysis suggests a potential benefit of adding ICIs to chemotherapy plus bevacizumab in pMMR mCRC; however, the evidence remains preliminary and hypothesis-generating, warranting further investigation in biomarker-driven trials and clarification of long-term outcomes.

23 August 2018 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
FAFumihiko Ando
Fumihiko Ando
AMAkihisa Matsuda
Akihisa Matsuda
MMMasao Miyashita
Masao Miyashita
SMSatoshi Matsumoto
Satoshi Matsumoto
NSNobuyuki Sakurazawa
Nobuyuki Sakurazawa
HYHiroshi Yoshida
Hiroshi Yoshida
Self-expandable metallic stent placement is a widely performed palliative procedure or bridge to surgery for obstructive colorectal cancer. However, the feasibility of this procedure for large bowel obstruction induced by effective neoadjuvant therapy is unclear. We herein report three such cases involving a 61-year-old man who underwent neoadjuvant chemoradiotherapy for lower rectal cancer, a 56-year-old woman who underwent neoadjuvant chemotherapy for lower rectal cancer, and a 63-year-old woman who underwent neoadjuvant chemotherapy for lower rectal cancer. All were emergently hospitalized with large bowel obstruction that developed while undergoing neoadjuvant therapy. Colonoscopy revealed smooth strictures caused by effective neoadjuvant therapy. Self-expandable metallic stents were placed across the obstruction as a bridge to surgery, and laparoscopic low anterior resection was uneventfully performed in all patients. We successfully treated three patients with large bowel obstruction induced by a good response to neoadjuvant therapy using self-expandable metallic stents as a bridge to surgery. Further studies with larger sample sizes are warranted to assess the feasibility of this strategy.

1 February 1990 in Journal of Applied Physiology
Verified
Journal Article
Closed access
FAFumihiko Ando
Fumihiko Ando
MAM. Arakawa
M. Arakawa
KKK. Kambara
K. Kambara
HMH. Miyazaki
H. Miyazaki
TSTakahiro Segawa
Takahiro Segawa
SHS. Hirakawa
S. Hirakawa
To investigate how fast and to what extent superior vena caval hypertension (SVCH) increases lung water in acute increased-permeability state, we studied the time course of lung water accumulation for 3 h in anesthetized dogs under different treatments: 1) controls without intervention (5 dogs), 2) SVCH alone (5 dogs), 3) mild lung microvascular injury induced by low-dose alloxan (75 mg/kg) alone (5 dogs), and 4) SVCH coupled with low-dose alloxan (5 dogs). Neither low-dose alloxan alone nor SVCH alone [superior vena caval pressure (Psvc) = 11.0 +/- 3.1 (SD) mmHg] increased lung water significantly. The SVCH coupled with low-dose alloxan (Psvc = 11.3 +/- 2.7 mmHg) doubled extravascular lung thermal volume measured by the thermal-dye dilution technique within 1 h (5.3 +/- 0.9 ml/kg at base line and 10.9 +/- 4.7 ml/kg at 1 h), then remained unchanged (12.5 +/- 5.7 ml/kg at 3 h). This increase in lung water was confirmed by gravimetric method (5.69 +/- 1.71 g/g blood-free dry wt). We conclude that SVCH is one of the factors that may promote lung water accumulation in increased-permeability state.

1 January 2017 in Nihon Ika Daigaku Igakkai Zasshi
Verified
Journal Article
Open access
PDF file
FAFumihiko Ando
Fumihiko Ando
YKYoshikazu Kanazawa
Yoshikazu Kanazawa
IFItsuo Fujita
Itsuo Fujita
DKDaisuke Kakinuma
Daisuke Kakinuma
HKHitoshi Kanno
Hitoshi Kanno
EUEiji Uchida
Eiji Uchida
There is no established surgical strategy to manage dissection of the infrapyloric lymph node in cases of gastric cancer occurring after a coronary artery bypass graft (CABG) with the right gastroepiploic artery (RGEA). We performed gastrectomy in three patients with gastric cancer who had undergone CABG using RGEA. In order to reduce the preoperative risk, we dissected the infrapyloric lymph node by skeletonizing the RGEA bypass graft without redoing the CABG. No recurrence of the disease has been observed in any of the three patients. It is important to implement a non-invasive surgical strategy for gastric cancer patients at high risk due to severe heart disease or advanced age. This gastrectomy procedure is an adequate noninvasive surgical strategy, because it enables a complete cure without coronary revascularization.